
Oracle Financial Services Software Limited
The current stock price of Oracle Financial Services Software Limited is ₹7,305.00, with a target price range between ₹6,939.75 and ₹7,670.25. The stock has experienced a price change of ₹-227.60 (-3.02%), reflecting recent market volatility.
Today's opening price was ₹7,528.00, while the previous close stood at ₹7,532.60.
The market trend suggests a potential downtrend, with investors exercising caution due to recent declines. Analysts recommend closely monitoring support levels.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
Oracle Financial Services Software Limited Price Chart
Oracle Financial Services Software Limited Pre Open Market Overview: 12-Mar-2025
Key Metrics:
- IEP (Indicative Equilibrium Price): 7528
- Previous Close Price: 7532.6
- Change: -4.60%
- Total Traded Volume: 280
- Total Buy Quantity: 1,192
- Total Sell Quantity: 1,748
Price | Buy Qty | Sell Qty |
---|---|---|
7,480.00 | 1.00 | 0.00 |
7,482.60 | 1.00 | 0.00 |
7,491.55 | 1.00 | 0.00 |
7,500.00 | 5.00 | 0.00 |
7,520.00 | 4.00 | 0.00 |
7,528.00 | 0.00 | 52.00 |
7,530.00 | 0.00 | 1.00 |
7,532.60 | 0.00 | 73.00 |
7,550.00 | 0.00 | 1.00 |
7,553.60 | 0.00 | 11.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 0
Order Book
Bid | Qty | Ask | Qty |
---|---|---|---|
0.00 | 0 | 0.00 | 0 |
0.00 | 0 | 0.00 | 0 |
0.00 | 0 | 0.00 | 0 |
0.00 | 0 | 0.00 | 0 |
0.00 | 0 | 0.00 | 0 |
Shareholding Patterns of Oracle Financial Services Software Limited
Key Trade Statistics of Oracle Financial Services Software Limited
Trade Information | Details |
---|---|
Traded Volume (Lakhs) | 2.30 |
Traded Value (₹ Cr.) | 167.26 |
Total Market Cap (₹ Cr.) | 63,442.36 |
Free Float Market Cap (₹ Cr.) | 17,209.37 |
Impact cost | 0.04 |
Quantity Traded | 230,330.00 |
Deliverable Quantity | 84,942.00 |
% of Quantity to Traded | 36.88 |
Security VaR | 15.52 |
Index VaR | N/A |
VaR Margin | 15.52 |
Extreme Loss Rate | 3.5 |
Adhoc Margin | N/A |
Applicable Margin Rate | 19.02 |
Face Value | 5 |
Key Price Statistics of Oracle Financial Services Software Limited
The 52-week high for Oracle Financial Services Software Limited was ₹13,220.00, recorded on 30-Dec-2024. On the other hand, the 52-week low stands at ₹7,022.55, with the lowest value recorded on 04-Jun-2024.
The upper band for trading is ₹8,285.85, and the lower band is ₹6,779.35. The price band is No Band%.
The stock's daily volatility stands at 2.41, while the annualized volatility is 46.04. The tick size for trading is ₹0.05.
Price Information | Details |
---|---|
52 Week High (30-Dec-2024) | 13,220.00 |
52 Week Low (04-Jun-2024) | 7,022.55 |
Upper Band | 8,285.85 |
Lower Band | 6,779.35 |
Price Band (%) | No Band |
Daily Volatility | 2.41 |
Annualised Volatility | 46.04 |
Tick Size | 0.05 |
Key Securities Statistics of Oracle Financial Services Software Limited
Securities Information | Details |
---|---|
Status | Listed |
Trading Status | Active |
Date of Listing | 28-Jun-2002 |
Adjusted P/E | 28.49 |
Symbol P/E | 28.49 |
Index | NIFTY MIDCAP 50 |
Macro-Economic Sector | Information Technology |
Sector | Information Technology |
Industry | IT - Software |
Basic Industry | Software Products |
Security Status of Oracle Financial Services Software Limited
Title | Details |
---|---|
Board Status | Main |
Trading Segment | Normal Market |
Session No. | - |
Class of Shares | Equity |
SDD Compliance | - |
Name of Compliance Officer | - |
Announcements of Oracle Financial Services Software Limited
Subject | Date |
---|---|
Copy of Newspaper Publication | 08-Mar-2025 |
Notice Of Shareholders Meetings-XBRL | 07-Mar-2025 |
Shareholders meeting | 07-Mar-2025 |
Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent | 03-Mar-2025 |
Appointment | 03-Mar-2025 |
Outcome of Board Meeting | 03-Mar-2025 |
Alteration Of Capital and Fund Raising-XBRL | 19-Feb-2025 |
Updates | 19-Feb-2025 |
Corporate Actions of Oracle Financial Services Software Limited
Face Value | Purpose | Ex-Date |
---|---|---|
5 | Annual General Meeting | 18-Jul-2024 |
5 | Interim Dividend - Rs 240 Per Share | 07-May-2024 |
5 | Annual General Meeting | 20-Jul-2023 |
5 | Interim Dividend - Rs 225 Per Share | 09-May-2023 |
5 | Annual General Meeting | 26-Jul-2022 |
5 | Interim Dividend - Rs 190 Per Share | 13-May-2022 |
5 | Annual General Meeting | 27-Jul-2021 |
5 | Interim Dividend - Rs 200 Per Share | 17-May-2021 |
5 | Annual General Meeting | 10-Aug-2020 |
5 | Interim Dividend -Rs 180 Per Share | 19-May-2020 |
5 | Annual General Meeting | 31-Jul-2019 |
5 | Annual General Meeting/Dividend- Rs 130 Per Share | 06-Aug-2018 |
5 | Annual General Meeting | 12-Sep-2017 |
5 | Interim Dividend Rs 170 Per Share | 19-Apr-2017 |
5 | Annual General Meeting/ Dividend -Rs 100/- Per Share | 30-Aug-2016 |
5 | Annual General Meeting/ Dividend - Rs 180/- Per Share | 03-Sep-2015 |
5 | Interim Dividend - Rs 485/- Per Share | 24-Sep-2014 |
5 | Annual General Meeting | 04-Sep-2014 |
5 | Annual General Meeting | 06-Aug-2013 |
5 | Annual General Meeting | 09-Aug-2012 |
Board Meetings of Oracle Financial Services Software Limited
Financial Results of Oracle Financial Services Software Limited
Company Directory of Oracle Financial Services Software Limited
Web Address | Office | Address | City |
---|---|---|---|
www.oracle.com/financialservices | Registered Office | Oracle Park Off Western Express Highway Goregaon East | MUMBAI |
www.oracle.com/financialservices | Transfer Agent | KFin Technologies Private Limited Selenium, Plot No. 31 & 32, Tower-B, Serilingampally, Nanakramguda, Financial District, Hyderabad | N/A |
Insider Trading of Oracle Financial Services Software Limited
Reg. Clause | Acq./Disp. | Sec. Value | Txn Type |
---|---|---|---|
7(2) | Mr. ONKARNATH BANERJEE | 6855 | Buy |
7(2) | Mr. ONKARNATH BANERJEE | 1174878 | Sell |
7(2) | MANISH BHANDARI | 1500 | Buy |
7(2) | Priyanshu Bhatt | 6492380 | Buy |
7(2) | Chad Randall Menke | 3986900 | Buy |
7(2) | Manish Bhandari | 1210000 | Sell |
7(2) | Chad Randall Menke | 5800000 | Sell |
7(2) | Makarand Padalkar | 60204294 | Sell |
7(2) | Mr. ONKARNATH BANERJEE | 1148662 | Sell |
7(2) | Makarand Padalkar | 30602624 | Sell |
7(2) | Avadhut Ketkar | 5500 | Buy |
7(2) | Vinay M Limaye | 998305 | Buy |
7(2) | MANISH BHANDARI | 2760 | Buy |
7(2) | Promod Radhakrishnan | 2544637 | Buy |
7(3) | MUSTAFA MOONIM | 5872966 | Sell |
7(2) | MANISH BHANDARI | 3814700 | Sell |
7(2) | Vinay M Limaye | 12284000 | Sell |
7(2) | VIJAYALAXMI BASAVARAJ KOTABAGI | 1643975 | Sell |
7(2) | LAKSHMI BALAJI | 635649 | Buy |
7(2) | LAKSHMI BALAJI | 657898 | Sell |
Annual Reports of Oracle Financial Services Software Limited
Investor Complaints of Oracle Financial Services Software Limited
Event Calendar of Oracle Financial Services Software Limited
Purpose | Details |
---|---|
Results/Others | To consider inter alia the following: (1) To adopt audited un-consolidated Indian GAAP Accounts for the quarter ended June 30, 2010; (2) To adopt audited consolidated Indian GAAP Accounts for the quarter ended June 30, 2010; (3) To consider allotment of shares to the eligible employees who have exercised their options under Employee Stock Option Scheme (ESOP), 2002 of the Company. |
Results/Others | To consider inter alia the following: (1) To adopt audited un-consolidated Indian GAAP Accounts for the quarter and half year ended September 30, 2010; (2) To adopt audited consolidated Indian GAAP Accounts for the quarter and half year ended September 30, 2010; (3) To consider allotment of shares to the eligible employees who have exercised their options under Employee Stock Option Scheme (ESOP), 2002 of the Company. |
Results/Others | To consider inter alia the following: (1) To adopt audited un-consolidated Indian GAAP Accounts for the quarter and nine months ended December 31, 2010; (2) To adopt audited consolidated Indian GAAP Accounts for the quarter and nine months ended December 31, 2010; (3) To consider allotment of shares to the eligible employees who have exercised their options under Employee Stock Option Scheme (ESOP), 2002 of the Company. |
Results/Dividend | To consider inter alia the following: (1) To adopt audited un-consolidated Indian GAAP Financials for the year ended March 31, 2011. (2) To adopt audited consolidated Indian GAAP Financials for the year ended March 31, 2011. (3) To recommend a dividend, if any, on equity shares. (4) To consider allotment of shares to the eligible employees who have exercised their options under Employee Stock Option Scheme (ESOP), 2002 of the Company. |
Results/Dividend | To inter alia consider the following :- (1) To approve audited standalone Indian GAAP Financials for the year ended March 31, 2012; (2) To approve audited consolidated Indian GAAP Financials for the year ended March 31, 2012; (3) To consider recommendation of a dividend, if any, on equity shares. |
Results/Dividend | To inter alia consider the following :- (1) To approve audited standalone Indian GAAP Financials for the year ended March 31, 2013; (2) To approve audited consolidated Indian GAAP Financials for the year ended March 31, 2013; (3) To consider recommendation of a dividend, if any, on equity shares. |
Results | to consider, inter alia, approval of unaudited standalone Indian GAAP Financials for the quarter ended June 30, 2013. |
Results | To consider, inter alia, approval of unaudited standalone Indian GAAP Financials for the quarter and half year ended September 30, 2013. |
Results | To consider, inter alia, approval of unaudited standalone Indian GAAP Financials for the quarter and nine months ended December 31, 2013. |
Results/Dividend | To inter alia consider the following:- 1. To approve audited standalone and consolidated Indian GAAP Financials for the year ended March 31, 2014,; and 2. To consider recommendation of a dividend, if any, on equity shares. Further, In terms of the Code of Internal Procedures and Conduct for Prevention of Insider Trading adopted by the Company, the Trading Window for dealing in equity shares of the Company is closed from May 1, 2014 till Tuesday, May 20, 2014 (both days inclusive) on account of declaration of financial results for the year ended March 31, 2014 on May 16, 2014. |
Results | to consider, inter alia, approval of unaudited standalone Indian GAAP Financials for the quarter ended June 30, 2014, as per Clause 41 of the listing agreement. In terms of the Code of Internal Procedures and Conduct for Prevention of Insider Trading adopted by the Company, the Trading Window for dealing in equity shares of the Company is closed from July 23, 2014 till August 11, 2014 (both days inclusive) on account of declaration of financial results for the quarter ended June 30, 2014. |
Dividend | Inter alia, declaration of Interim Dividend to the equity shareholders of the Company. |
Results | To consider, inter alia, approval of unaudited standalone and consolidated Indian GAAP Financials for the quarter and half year ended September 30, 2014. |
Results | To consider, inter alia, approval of unaudited standalone and consolidated Indian GAAP Financials for the quarter and nine months ended December 31, 2014, as per Clause 41 of the listing agreement. |
Results/Dividend | To consider, inter alia, the following:- 1. To approve audited standalone and consolidated Indian GAAP Financials for the year ended March 31, 2015, as per Clause 41 of the listing agreement; and 2.To consider recommendation of a dividend, if any, on equity shares. |
Results/Dividend | The Company had informed the Exchange regarding a meeting of the Board of Directors of the Company schedule to be held on May 14, 2015, To consider, inter alia, the following:- 1. To approve audited standalone and consolidated Indian GAAP Financials for the year ended March 31, 2015, as per Clause 41 of the listing agreement; and 2.To consider recommendation of a dividend, if any, on equity shares. The Company has now informed the Exchange that the meeting of the Board of Directors has now been rescheduled to May 15, 2015 (Revised). |
Results | to consider, inter alia, approval of unaudited standalone and consolidated Indian GAAP Financials for the quarter ended June 30, 2015, as per Clause 41 of the listing agreement. |
Results | to consider, inter alia, approval of unaudited standalone and consolidated Indian GAAP Financials for the quarter and half year ended September 30, 2015. |
Results | To consider, inter alia, approval of unaudited standalone and consolidated Indian GAAP Financials for the quarter and nine months period ended December 31, 2015. |
Results/Dividend | to consider, inter alia, the following:1. To approve audited standalone and consolidated Indian GAAP Financials for the year ended March 31, 2016, as per Regulation 29 read with Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015.2. To consider recommendation of a dividend, if any, on equity shares. |
Results | to consider, inter alia, approval of unaudited standalone and consolidated Ind-AS financial results as per Regulation 29 read with Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. In terms of the Code of Internal Procedures and Conduct for Prevention of Insider Trading adopted by the Company, the Trading Window for dealing in equity shares of the Company is closed from July 29, 2016 until August 16, 2016 (both days inclusive) on account of declaration of financial results for the quarter ended June 30, 2016. |
Results | To consider, inter alia, approval of unaudited standalone and consolidated Ind-AS financial results for the quarter and half year ended September 30, 2016. |
Results | to consider, inter alia, approval of unaudited standalone and consolidated Ind-AS financial results for the quarter and nine month period ended December 31, 2016. In terms of the Code of Internal Procedures and Conduct for Prevention of Insider Trading adopted by the Company, the Trading Window for dealing in equity shares of the Company is closed from Monday, January 23, 2017 until Friday, February 10, 2017 (both days inclusive) on account of declaration of financial results for the quarter and nine month period ended December 31, 2016. |
Dividend | inter alia, to consider and approve declaration of Interim Dividend, if any, on the equity shares of the Company for the financial year 2016-17. Further, in terms of the Code of Internal Procedures and Conduct for Prevention of Insider Trading adopted by the Company, the Trading Window for dealing in equity shares of the Company will remain closed from March 22, 2017 until Friday, March 31, 2017 (both days inclusive). |
Results/Dividend | inter alia, to consider, the following: 1. approval of audited standalone and consolidated Ind-AS financial results for the quarter and year ended March 31, 2017; and 2. recommendation of a dividend, if any, on equity shares. |
Results | Inter alia, to consider, approval of unaudited standalone and consolidated Ind-AS financial results for the quarter ended June 30, 2017. |
Results | inter alia, to consider, approval of unaudited standalone and consolidated Ind-AS financial results for the quarter and half year ended September 30, 2017. |
Others | to consider allotment of shares to the eligible employees who have chosen to exercise their options under prevailing Employees Stock Option Schemes of the Company. |
Results | Inter alia, to consider, approval of unaudited standalone and consolidated Ind-AS financial results for the quarter and nine month period ended December 31, 2017. |
Financial Results/Dividend | To consider and approve audited standalone and consolidated Ind-AS financial results for the quarter and year ended March 31, 2018 and recommendation of a dividend, if any, on equity shares. |
Financial Results | o consider and approve the financial results for the period ended Jun 30, 2018 and the Trading Window for dealing in equity shares of the Company is closed from Wednesday, August 1, 2018 until Thursday, August 16, 2018 (both days inclusive) on account of declaration of financial results for the quarter ended June 30, 2018. |
Financial Results | To consider and approve the financial results for the quarter and half year ended September 30, 2018 |
Financial Results | To consider and approve the financial results for the period ended December 31, 2018 |
Financial Results | To consider and approve the financial results for the period ended March 31, 2019 and recommendation of dividend, if any. |
Financial Results | To consider and approve the financial results for the period ended Jun 30, 2019 |
Financial Results | To consider and approve the financial results for the quarter and half year ended September 30, 2019 |
Financial Results | To consider and approve the financial results for the period ended December 31, 2019 |
Dividend | To consider declaration of Interim Dividend, if any, for the financial year 2019-20. |
Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2020 and final dividend, if any. |
Financial Results | To consider and approve the financial results for the period ended June 30, 2020 |
Financial Results | To consider and approve the financial results for the period ended September 30, 2020 |
Financial Results | To consider and approve the financial results for the period ended December 31, 2020 |
Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2021 and dividend, if any, on equity shares |
Financial Results | To consider and approve the financial results for the period ended Jun 30, 2021 |
Financial Results | To consider and approve the financial results for the period ended September 30, 2021 |
Financial Results | To consider and approve the financial results for the period ended December 31, 2021 |
Financial results | Oracle Financial Services Software Limited has informed the Exchange about Board Meeting to be held on 20-Jul-2022 to consider financial statements for the period ended June 2022 |
Financial results | Oracle Financial Services Software Limited has informed the Exchange about Board Meeting to be held on 19-Oct-2022 to consider financial statements for the period ended September 2022 |
Financial Results | To consider and approve the financial results for the period ended December 31, 2022 |
Financial Results/Dividend | To consider and approve the audited financial results for the period ended March 31, 2023 and recommendation of dividend, if any. |
Financial Results | To consider and approve the financial results for the period ended Jun 30, 2023 |
Financial Results | To consider and approve the financial results for the period ended September 30, 2023 |
Financial Results | To consider and approve the financial results for the period ended December 31, 2023 |
Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2024 and recommendation of dividend, if any. |
Financial Results | To consider and approve the financial results for the period ended Jun 30, 2024 |
Financial Results | To consider and approve the financial results for the period ended September 30, 2024 |
Financial Results | To consider and approve the financial results for the period ended December 31, 2024 |
Share Transfers of Oracle Financial Services Software Limited
Voting Results of Oracle Financial Services Software Limited
Date of Mtg. | Mtg. Type | Resolution |
---|---|---|
25-JUL-2024 | AGM | To receive, consider and adopt the Audited Financial Statements (including the consolidated financial statements) of the Company for the financial year ended March 31, 2024 and the Reports of the Board of Directors and Auditors thereon. |
25-JUL-2024 | AGM | To confirm the payment of interim dividend of ᅡ 240 per equity share already paid, as the final dividend for the financial year ended March 31, 2024 |
25-JUL-2024 | AGM | To appoint a Director in place of Mr. Vincent Secondo Grelli (DIN: 08262388) who retires by rotation and being eligible, offers himself for re-appointment. |
25-JUL-2024 | AGM | To appoint a Director in place of Ms. Kimberly Woolley (DIN: 07741017) who retires by rotation and being eligible, offers herself for re-appointment. |
11-JAN-2024 | Postal Ballot | Appointment of Mr. Mrugank Paranjape (DIN: 02162026) as Non-Executive, Independent Director of the Company |
30-NOV-2023 | Postal Ballot | Appointment of Mr. Makarand Padalkar (DIN: 02115514) as the Managing Director and Chief Executive Officer of the Company |
30-NOV-2023 | Postal Ballot | Appointment of Mr. Gopala Ramanan Balasubramaniam (DIN: 02785489) as the Non-Executive, Non-Independent Director of the Company |
27-JUL-2023 | AGM | To receive, consider and adopt the Audited Financial Statements (including the consolidated financial statements) of the Company for the financial year ended March 31, 2023 and the Reports of the Board of Directors and Auditors thereon. |
27-JUL-2023 | AGM | To approve re-appointment of Ms. Jane Murphy (DIN: 08336710) as an Independent Director of the Company for a further term of five years from January 1, 2024 up to December 31, 2028 |
27-JUL-2023 | AGM | To confirm the payment of interim dividend of ᅡ 225 per equity share already paid, as the final dividend for the financial year ended March 31, 2023. |
27-JUL-2023 | AGM | To appoint a Director in place of Mr. Chaitanya Kamat (DIN: 00969094) who retires by rotation and being eligible, offers himself for re-appointment. |
27-JUL-2023 | AGM | To appoint a Director in place of Mr. Harinderjit Singh (DIN: 06628566) who retires by rotation and being eligible, offers himself for re-appointment. |
03-AUG-2022 | AGM | Adoption of audited financial statements (including the consolidated financial statements) of the Company for the financial year ended March 31, 2022 and the Reports of the Board of Directors and the Auditors thereon. |
03-AUG-2022 | AGM | Adoption of a new set of Articles of Association in place of the existing Articles of Association of the Company. |
03-AUG-2022 | AGM | Appointment M/s. S R Batliboi & Associates LLP, Chartered Accountants as the Statutory Auditors of the Company to hold office from the conclusion of this AGM till the conclusion of the 38th AGM to be held in the year 2027. |
03-AUG-2022 | AGM | Confirmation of the payment of interim dividend of Rs. 190 per equity share of Rs. 5 each, which was paid in May 2022, as the final dividend for the financial year ended March 31, 2022. |
03-AUG-2022 | AGM | Appointment of a Director in place of Mr. Makarand Padalkar (DIN: 02115514), who retires by rotation and, being eligible, offers himself for re-appointment. |
03-AUG-2022 | AGM | Appointment of a Director in place of Mr. Yong Meng Kau (DIN: 08234739), who retires by rotation and, being eligible, offers himself for re-appointment. |
04-AUG-2021 | AGM | Adoption of the audited financial statements (including the consolidated financial statements) of the Company for the financial year ended March 31, 2021 and the Reports of the Board of Directors and the Auditors thereon. |
04-AUG-2021 | AGM | Appointment of a Director in place of Ms. Kimberly Woolley (DIN: 07741017), who retires by rotation and, being eligible, offers herself for re-appointment. |
FAQs on Oracle Financial Services Software Limited
Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.